Showing results (231-240 of 373) with videos related to
Sort By:
Pageof 38
Neurology|March 27, 2016
Statins and risk of poststroke hemorrhagic complicationsJan F Scheitz, Rachael L MacIsaac, Azmil H Abdul-Rahim, et al.Age and Ageing|February 17, 2022
The COVID-19 pandemic has highlighted the need to invest in care home research infrastructureAdam L Gordon, Caroline Rick, Ed Juszczak, et al.Journal of Stroke|February 7, 2025
Non-Inferiority Trials in Stroke Research: What Are They, and How Should We Interpret Them?Linxin Li, Vasileios-Arsenios Lioutas, Ralph K Akyea, et al.European Stroke Journal|July 17, 2018
Dependency and health utilities in stroke: Data to inform cost-effectiveness analysesMyzoon Ali, Rachael MacIsaac, Terence J Quinn, et al.BMC Geriatrics|August 26, 2022
Development of a core outcome set for the evaluation of interventions to prevent COVID-19 in care homes (COS-COVID-PCARE Study)Victoria Shepherd, Ishrat Islam, Fiona Wood, et al.F1000Research|August 11, 2025
Developing treatments for cerebral small vessel disease: a scoping review of licensed interventions for potential repurposingPhilip M Bath, Elizabeth P Phan, Gwynneth Clay, et al.European Stroke Journal|October 19, 2020
Protocol: The Lacunar Intervention Trial 2 (LACI-2). A trial of two repurposed licenced drugs to prevent progression of cerebral small vessel diseaseJoanna Wardlaw, Philip M W Bath, Fergus Doubal, et al.European Stroke Journal|January 28, 2020
Women in the European Stroke Organisation: One, two, many… - A Top Down and Bottom Up approachElse Charlotte Sandset, Diana Aguiar de Sousa, Hanne Christensen, et al.European Stroke Journal|July 30, 2024
Outcome 1 year after ICH: Data from the Tranexamic acid for IntraCerebral Haemorrhage 2 (TICH-2) trialZhe Kang Law, Chaamanti Sivakumar Menon, Lisa J Woodhouse, et al.Lancet (London, England)|August 8, 2016
Human neural stem cells in patients with chronic ischaemic stroke (PISCES): a phase 1, first-in-man studyDheeraj Kalladka, John Sinden, Kenneth Pollock, et al.Pageof 38